sb743921
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2004 (NCT00136513)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Kinesin-like protein 1INHIBITOR
KIF11 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- sb743921
- sb 743921
- sb-743921
- sb-743921
- sb-743921
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00343564 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2006 | Columbia University, Cytokinetics |
| NCT00136513 | Phase 1 | Apr 1, 2004 | GlaxoSmithKline |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Columbia University | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Cytokinetics | For profit | 1 | 1 | 1 | 2006 |
| GlaxoSmithKline | For profit | 1 | 1 | 1 | 2004 |
3 organizations
Page 1 / 1